Clinical trial

Glycemic Variability of Combination Therapies in T2DM

NCT07442006

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-10-29

PhasePHASE4

Study timeline

Study start (actual)2025-10-29Date precision: day

Registry last updated2026-03-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Interventions

Empagliflozin/MetforminDRUG

AnagliptinDRUG

MetforminDRUG · verified · RxNorm: metformin

Empagliflozin/LinagliptinDRUG

Sponsors & collaborators

JW Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07442006 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.